![Philippe van Holle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe van Holle
No open positions remaining
Profile
Philippe van Holle is the founder of Amsterdam Molecular Therapeutics (AMT) Holding NV, which was founded in 1998.
He held the title of Member-Supervisory Board from 2010 to 2013.
Mr. van Holle's former jobs include being an Independent Director at Argos Therapeutics, Inc. from 2015 to 2016, and being the President of Celgene International SARL from 2005 to 2014.
He also held the title of Principal at Amgen Europe BV.
Mr. van Holle received an MBA from Cornell University and an undergraduate degree from the University of Antwerp in 1976.
Former positions of Philippe van Holle
| Companies | Position | End |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | Director/Board Member | 2016-12-12 |
Celgene International SARL
 Celgene International SARL Pharmaceuticals: MajorHealth Technology Operates as bio-pharmaceutical company, which discovers, develops and commercializes therapies for unmet medical needs in cancer | President | 2014-09-30 |
Amsterdam Molecular Therapeutics (AMT) Holding NV
 Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Specializes in human gene therapy for metabolic disorders and ocular diseases | Founder | 2013-03-10 |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | - |
Training of Philippe van Holle
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
46
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Celgene International SARL
Celgene International SARL Pharmaceuticals: MajorHealth Technology Operates as bio-pharmaceutical company, which discovers, develops and commercializes therapies for unmet medical needs in cancer | Health Technology |
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amsterdam Molecular Therapeutics (AMT) Holding NV
Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Specializes in human gene therapy for metabolic disorders and ocular diseases | Commercial Services |
Amgen Europe BV
Amgen Europe BV Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
University of Antwerp
 University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Philippe van Holle
Choose MarketScreener 
